Announcements Trials
Browse Landscape

Phase

Phase 1 183Phase 1/2 30Phase 2 16Phase NA 5Phase EARLY_PHASE1 3Phase 4 2Phase 3 2

Status

Terminated 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 3INDUSTRY 3OTHER_GOV 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other solid neoplasm 3

Conditions

Multiple Myeloma 19Solid Tumor 18Breast Neoplasms 14Sarcoma 13Head and Neck Neoplasms 13Colorectal Neoplasms 13Neoplasms 12Lymphoma, B-Cell 12Squamous Cell Carcinoma of Head and Neck 11Pancreatic Neoplasms 11Leukemia, Myeloid, Acute 11Stomach Neoplasms 10Melanoma 10Lymphoma 9Carcinoma, Non-Small-Cell Lung 9Lung Neoplasms 8Prostatic Neoplasms 7Leukemia 7Burkitt Lymphoma 7Advanced Solid Tumors 7Ovarian Neoplasms 6Hematologic Neoplasms 6Glioblastoma 6Recurrence 5Osteosarcoma 5Lymphoma, Non-Hodgkin 5Carcinoma, Hepatocellular 5Triple Negative Breast Neoplasms 4Small Cell Lung Carcinoma 4Neoplasm Metastasis 4

Interventions

spartalizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × INDUSTRY × Solid Tumors × Clear all
NCT07583953 2026-05-13

An Exploratory Study of Personalized Cancer Vaccine in Adjuvant Therapy of Solid Tumors

Suzhou Abogen Biosciences Co., Ltd.

Phase EARLY_PHASE1 Not yet recruiting
50 enrolled
Other solid neoplasm

Solid Tumors

NCT07505069 2026-04-01

Exploring the Clinical Value of RT01-89Zr PET Imaging in Solid Tumors

Nanolattix Biotechnology Co., Ltd.

Phase EARLY_PHASE1 Recruiting
10 enrolled
Other solid neoplasm

Solid Tumors

NCT04237649 2025-05-18

KAZ954 Alone and With PDR001, NZV930 and NIR178 in Advanced Solid Tumors

Novartis

Phase EARLY_PHASE1 Terminated
77 enrolled
Other solid neoplasm

Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡